169 related articles for article (PubMed ID: 3511088)
1. Human-human hybridoma autoantibodies with both anti-DNA and rheumatoid factor activities.
Rauch J; Tannenbaum H; Straaton K; Massicotte H; Wild J
J Clin Invest; 1986 Jan; 77(1):106-12. PubMed ID: 3511088
[TBL] [Abstract][Full Text] [Related]
2. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
[TBL] [Abstract][Full Text] [Related]
3. Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Jan; 134(1):180-6. PubMed ID: 3964813
[TBL] [Abstract][Full Text] [Related]
4. Binding characteristics of human hybridoma IgG and IgM rheumatoid factors: influence of IgG isotype and carbohydrate content.
Newkirk MM; Rauch J; Commerford K
J Rheumatol Suppl; 1992 Jan; 32():54-5; discussion 55-8. PubMed ID: 1613734
[TBL] [Abstract][Full Text] [Related]
5. Polyfunctional properties of hybridoma lupus anticoagulant antibodies.
Rauch J; Tannenbaum H; Senécal JL; Janoff AS; Cullis PR; Frojmovic MM
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():132-7. PubMed ID: 3112375
[TBL] [Abstract][Full Text] [Related]
6. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus.
Traycoff RB; Rogers WW; Gregory SA
J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781
[TBL] [Abstract][Full Text] [Related]
7. IgG antinuclear antibodies with cross-reactive rheumatoid factor activity.
Darwin BS; Grudier JP; Klatt CL; Pisetsky DS
J Immunol; 1986 Dec; 137(12):3796-801. PubMed ID: 3782796
[TBL] [Abstract][Full Text] [Related]
8. A sensitive and class specific solid phase enzyme immunoassay for anti-DNA autoantibodies in supernatants of lymphocyte cultures and human hybridomas.
Hiepe F; Kiessig ST; Jahn S; Volk HD; Grunow R; Apostoloff E; von Baehr R
Biomed Biochim Acta; 1986; 45(7):K29-35. PubMed ID: 3539108
[TBL] [Abstract][Full Text] [Related]
9. Sensitive solid phase radioimmunoassay for the detection of anti-DNA autoantibodies.
Rauch J; Massicotte H; Wild J; Tannenbaum H
J Rheumatol; 1985 Jun; 12(3):482-6. PubMed ID: 4045848
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mouse and human monoclonal antibodies cross-reactive with SLE serum antibodies to guanosine.
Weisbart RH; Chan G; Kacena A; Saxton RE
J Immunol; 1984 Jun; 132(6):2909-12. PubMed ID: 6725946
[TBL] [Abstract][Full Text] [Related]
11. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
12. Hybridoma SLE autoantibodies: insights for the pathogenesis of autoimmune disease.
Pisetsky DS
Clin Immunol Rev; 1984; 3(2):169-234. PubMed ID: 6084573
[No Abstract] [Full Text] [Related]
13. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the GM 4672 human lymphoblastoid cell line and analysis of its use as a fusion partner in the generation of human-human hybridoma autoantibodies.
Rioux JD; Rauch J; Zdarsky E; Newkirk MM
Hum Antibodies Hybridomas; 1993 Jul; 4(3):107-14. PubMed ID: 7689347
[TBL] [Abstract][Full Text] [Related]
15. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus.
Stevenson FK; Longhurst C; Chapman CJ; Ehrenstein M; Spellerberg MB; Hamblin TJ; Ravirajan CT; Latchman D; Isenberg D
J Autoimmun; 1993 Dec; 6(6):809-25. PubMed ID: 8155258
[TBL] [Abstract][Full Text] [Related]
16. Detection of cross reactive anti-DNA antibody idiotypes on tissue-bound immunoglobulins from skin biopsies of lupus patients.
Isenberg D; Dudeney C; Wojnaruska F; Bhogal BS; Rauch J; Schattner A; Naparstek Y; Duggan D
J Immunol; 1985 Jul; 135(1):261-4. PubMed ID: 3873490
[TBL] [Abstract][Full Text] [Related]
17. Quantitative aspects of lupus anti-DNA autoantibody specificity.
Edberg JC; Taylor RP
J Immunol; 1986 Jun; 136(12):4581-7. PubMed ID: 3486904
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against polyriboadenylic acid in systemic lupus erythematosus and rheumatoid arthritis demonstrated by ELISA. Prevalence of and relation to antibodies against DNA and extractable nuclear antigens.
Gripenberg M; Piirainen H; Linder E
Scand J Rheumatol; 1981; 10(1):33-7. PubMed ID: 6971488
[TBL] [Abstract][Full Text] [Related]
19. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
[No Abstract] [Full Text] [Related]
20. Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjögren's syndrome and rheumatoid arthritis.
Karsh J; Halbert SP; Anken M; Klima E; Steinberg AD
Int Arch Allergy Appl Immunol; 1982; 68(1):60-9. PubMed ID: 6978853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
